We demonstrate here that the bioactive lipid sphingosine 1-phosphate (S1P) uses sphingosine 1-phosphate receptor 4 (S1P 4 ) and human epidermal growth factor receptor 2 (HER2) to stimulate the extracellular signal regulated protein kinase 1/2 (ERK-1/2) pathway in MDA-MB-453 cells. This was based on several lines of evidence. First, the S1P stimulation of ERK-1/2 was abolished by JTE013, which we show here is an S1P 2/4 antagonist and reduced by siRNA knockdown of S1P 4 . Second, the S1P-stimulated activation of ERK-1/2 was almost completely abolished by a HER2 inhibitor (ErbB2 inhibitor II) and reduced by siRNA knockdown of HER2 expression. Third, phyto-S1P, which is an S1P 4 agonist, stimulated ERK-1/2 activation in an S1P 4 -and HER2-dependent manner. Fourth, FTY720 phosphate, which is an agonist at S1P 1,3,4,5 but not S1P 2 stimulated activation of ERK-1/2. Fifth, S1P stimulated the tyrosine phosphorylation of HER2, which was reduced by JTE013. HER2 which is an orphan receptor tyrosine kinase is the preferred dimerization partner of the EGF receptor. However, EGF-stimulated activation of ERK-1/2 was not affected by siRNA knockdown of HER2 or by ErbB2 (epidermal growth factor receptor 2 (or HER2)) inhibitor II in MDA-MB-453 cells. Moreover, S1P-stimulated activation of ERK-1/2 does not require an EGF receptor. Thus, S1P and EGF function in a mutually exclusive manner. In conclusion, the magnitude of the signaling gain on the ERK-1/2 pathway produced in response to S1P can be increased by HER2 in MDA-MB-453 cells. The linkage of S1P with an oncogene suggests that S1P and specifically S1P 4 may have an important role in breast cancer progression.There is increasing evidence that suggests a role for the bioactive lipid sphingosine 1-phosphate (S1P) 2 in breast cancer. S1P binds to a family of five GPCR, termed S1P n (where n ϭ 1-5), that are differentially coupled to heterotrimeric G proteins (G i , G q , and G 12/13 ) to regulate various effectors such as MAP kinases linked to diverse cellular processes such as proliferation, cell survival, and differentiation (1-13). The specificity of signaling in terms of which kinase modules are activated is dependent upon the receptor sub-type involved and is cell context-specific. S1P is produced by the enzyme sphingosine kinase (SK), which catalyzes the phosphorylation of sphingosine to produce S1P. SK (which exists as two isoforms termed SK1 and SK2) is activated by agonists such as antigen, plateletderived growth factor, nerve growth factor, tumor necrosis factor ␣, and epidermal growth factor (EGF), resulting in an increase in intracellular S1P. SK1 activation and/or translocation is regulated by phosphorylation catalyzed by ERK-1/2 and by CIB1 (calcium and integrin-binding protein 1) (14,15). S1P has an important role in breast cancer cells in terms of regulating survival, proliferation, and migration (16 -18). For instance, ectopic expression of SK1 increased S1P levels, estrogen-dependent tumorigenesis, and blocked apoptosis of MCF-7 cells induced by anticancer drug...